5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The Global Leadership Initiative on Malnutrition (GLIM) criteria have been recently launched by consensus of the major nutrition societies. GLIM criteria are partly constructed on the previous definition of malnutrition developed by the European Society of Clinical Nutrition and Metabolism (ESPEN). We aimed to assess malnutrition according to the ESPEN and GLIM criteria at baseline and to determine the corresponding risk of mortality during a 4‐year follow‐up in community‐dwelling older adults from the SarcoPhAge ( Sarcopenia and Physical Impairment with advancing Age) study. The relationship between malnutrition and incidence of 4‐year adverse health consequences (institutionalization, hospitalization, falls, and fractures) was assessed.

          Methods

          This prospective population‐based cohort was part of SarcoPhAge, which included 534 older adults in Belgium, followed up from 2013 to 2019. Community‐dwelling healthy volunteers ≥65 years old were recruited. Mortality and adverse health consequences were collected annually by interview or phone call. Baseline malnutrition was defined according to the GLIM and ESPEN criteria. Agreement between the two definitions was reported by Cohen's kappa coefficient. Adjusted Cox regression and Kaplan–Meier survival curves were performed for malnutrition. Logistic regression was used for the other outcomes.

          Results

          From 534 subjects in SarcoPhAge, the records for 411 participants (73.2 ± 6.05 years old; 55.7% women) had all the variables needed to apply the GLIM criteria. Prevalence of baseline malnutrition was 23.4% for GLIM and 7% for ESPEN criteria ( k = 0.30, low agreement). The adjusted Cox regression showed a significant increased mortality risk according to malnutrition status as defined by the GLIM [adjusted hazard ratio = 4.41 (95% confidence interval: 2.17–8.97)] and ESPEN [adjusted hazard ratio = 2.76 (95% confidence interval: 1.16–6.58)] criteria. Survival curves differed significantly between malnourished and non‐malnourished groups, regardless of the definition used (log rank P < 0.001 for both). No association was found between baseline malnutrition according to these two criteria and 4‐year risk of institutionalization, hospitalization, falls, or fractures (all P > 0.05).

          Conclusions

          Malnutrition according to the GLIM criteria was associated with a 4.4‐fold higher mortality risk, double that of the ESPEN criteria, during a 4‐year follow‐up. No association was found between malnutrition according to these two criteria and incidence of other health adverse consequences. GLIM criteria anticipate mortality and might guide interventions, with important implications for clinical practice and research.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: not found
          • Article: not found

          "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Sarcopenia: revised European consensus on definition and diagnosis

            Abstract Background in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

                Bookmark

                Author and article information

                Contributors
                dolores.sanchez@uliege.be
                Journal
                J Cachexia Sarcopenia Muscle
                J Cachexia Sarcopenia Muscle
                10.1007/13539.2190-6009
                JCSM
                Journal of Cachexia, Sarcopenia and Muscle
                John Wiley and Sons Inc. (Hoboken )
                2190-5991
                2190-6009
                13 July 2020
                October 2020
                : 11
                : 5 ( doiID: 10.1002/jcsm.v11.5 )
                : 1200-1211
                Affiliations
                [ 1 ] WHO Collaborating Centre for Public Health aspects of musculo‐skeletal health and aging, Division of Public Health, Epidemiology and Health Economics University of Liège Liège Belgium
                [ 2 ] Geriatrics Department Parc de Salut Mar Barcelona Spain
                [ 3 ] Rehabilitation Research Group Hospital Del Mar Medical Research Institute (IMIM) Barcelona Spain
                [ 4 ] School of Medicine Universitat Pompeu Fabra Barcelona Spain
                [ 5 ] Chair for Biomarkers of Chronic Diseases, Biochemistry Department College of Science, King Saud University Riyadh KSA
                [ 6 ] Royal Belgian Society of Laboratory Medicine Verviers Belgium
                [ 7 ] Department of Clinical Chemistry University of Liège, CHU–Sart Tilman Liège Belgium
                Author notes
                [*] [* ] Correspondence to: Dolores Sanchez‐Rodriguez, MD, PhD, WHO Collaborating Centre for Public Health Aspects of Musculo‐Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics, University of Liège, CHU–Sart Tilman, Quartier Hôpital, Avenue Hippocrate 13 (Bât. B23), Liège 4000, Belgium. Tel: +32 43 66 28 12/+32 493 43 27 50, Email: dolores.sanchez@ 123456uliege.be
                [*]

                Contributed equally

                Author information
                https://orcid.org/0000-0001-8662-5172
                https://orcid.org/0000-0003-2824-1589
                https://orcid.org/0000-0001-6290-752X
                https://orcid.org/0000-0003-0947-2226
                https://orcid.org/0000-0003-4269-9393
                https://orcid.org/0000-0002-0827-5303
                Article
                JCSM12574 JCSM-D-19-00316
                10.1002/jcsm.12574
                7567139
                32657045
                e2078ec1-0c40-4cde-ba98-4fa0d739ebf1
                © 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 26 July 2019
                : 28 February 2020
                : 17 March 2020
                Page count
                Figures: 2, Tables: 4, Pages: 12, Words: 5388
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                October 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.2 mode:remove_FC converted:16.10.2020

                Orthopedics
                diagnosis,glim,malnutrition,prospective study,sarcophage
                Orthopedics
                diagnosis, glim, malnutrition, prospective study, sarcophage

                Comments

                Comment on this article